Myocardial injury caused by infection of coronavirus.

Author: Yanxia HUANG ¹ ; Mei MENG ; Dechang CHEN
Author Information

1. Department of Critical Care Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China. Corresponding author: Chen Dechang, Email: 18918520002@189.cn.
Publication Type:Journal Article
MeSH: Animals; COVID-19; Angiotensin-Converting Enzyme 2; SARS-CoV-2; Endothelial Cells; Peptidyl-Dipeptidase A/genetics*
From: Chinese Critical Care Medicine 2023;35(6):665-668
CountryChina
Language:Chinese
Abstract: Coronaviruses are single-stranded RNA viruses that are common in animals. In the past 20 years, there have been three large-scale epidemics of coronaviruses, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease (COVID). Heart disease is an independent risk factor for severe COVID. At the same time, SARS-CoV-2 infection is often complicated with myocardial injury, which is closely related to poor prognosis. The receptors of SARS coronavirus are angiotensin-converting enzyme 2 (ACE2) and CD209L, among which ACE2 is the main receptor, and ACE2 is abundant in the heart. The receptor of MERS-coronavirus is dipeptide peptidase 4 (DPP4), which is not expressed in myocardial cells, but existed in vascular endothelial cells and blood. These receptors are important factors for the myocardial injury caused by coronavirus infection.